SCHEMBL4708569

SCHEMBL4708569

C1=CN(c2ccncc2)CN1Cc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 1/20 0.40
CDK8 P49336 1/20 0.40
CYP19A1 P11511 2/20 0.39
P2RX7 Q99572 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
MAPT P10636 2/20 0.39
POLB P06746 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
TBXAS1 P24557 1/20 0.39
QPCT Q16769 1/20 0.39
CYP4Z1 Q86W10 1/20 0.39
QPCTL Q9NXS2 1/20 0.39
HTR6 P50406 1/20 0.38
KCNH2 Q12809 1/20 0.38
DYRK1A Q13627 1/20 0.38
CCR2 P41597 1/20 0.38
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28288411 0.90 DRD4 (0.43) CYP19A1CYP11B1CYP11B2SIGMAR1
Bromide SCHEMBL28360122 0.88 DRD4 (0.42) CYP19A1CYP11B1CYP11B2SIGMAR1
Bromide SCHEMBL2531385 0.83 SIGMAR1 (0.37) CCNCCDK8CYP19A1CYP11B1CYP11B2
Pyridine SCHEMBL27430865 0.82 CYP19A1 (0.44) CCNCCDK8CYP19A1P2RX7CYP1A2
SCHEMBL28283766 0.82 LMNA (0.49) MAPTPOLBSIGMAR1NPSR1
Hydrochloric Acid SCHEMBL1647577 0.80 DRD4 (0.39) SIGMAR1
Bromide SCHEMBL30422921 0.80 DRD4 (0.39) SIGMAR1
Hydrochloric Acid SCHEMBL1647575 0.80 DRD4 (0.39) SIGMAR1
SCHEMBL16429033 0.78 MAPT (0.50) CYP3A4MAPTNPSR1
SCHEMBL1044027 0.78 SIGMAR1 (0.52) CYP19A1POLBSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910369-A1 FUSED HETEROCYCLES AS LCK INHIBITORS Astellas Pharma Inc. (JP) 2008-04-16 EP claimed
WO-2007013673-A1 FUSED HETEROCYCLES AS LCK INHIBITORS ASTELLAS PHARMA INC. (JP) 2007-02-01 WO claimed
CN-104797585-A Aminoimidazopyridazines Bayer Pharma AG 2015-07-22 CN disclosed